406 - Post-Transplant Cyclophosphamide (PTCy) Is Associated with Superior Gvhd-Free, Relapse-Free Survival (GRFS) in HLA-Mismatched Unrelated Donor (MMUD) Hematopoietic Cell Transplantation

Journal article

Peer reviewed

Antonio M Jimenez Jimenez, Miguel-Angel Perales, Sean M Devlin, Samantha Brown, Lazaros J Lekakis, Craig S Sauter, Denise Pereira, Trent P Wang, Doris M Ponce, Amer Beitinjaneh, …

Transplantation and cellular therapy, Vol.28(3), pp.S315-S316

2022-03

Metrics

34 Record Views

Title: 406 - Post-Transplant Cyclophosphamide (PTCy) Is Associated with Superior Gvhd-Free, Relapse-Free Survival (GRFS) in HLA-Mismatched Unrelated Donor (MMUD) Hematopoietic Cell Transplantation
Creators: Antonio M Jimenez Jimenez
Miguel-Angel Perales
Sean M Devlin
Samantha Brown
Lazaros J Lekakis
Craig S Sauter
Denise Pereira
Trent P Wang
Doris M Ponce
Amer Beitinjaneh
Stephanie Chinapen
Mark Goodman
Krishna V Komanduri
Brian C Shaffer
Publication Details: Transplantation and cellular therapy, Vol.28(3), pp.S315-S316
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031713370602976